Xiujun Liu
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
-
- Cancer therapeutics and mechanisms
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer therapeutics and mechanisms 8
- Cancer-related gene regulation 4
- Oncology 27
- Peptidase Inhibition and Analysis 8
- HER2/EGFR in Cancer Research 6
- Cancer-related Molecular Pathways 4
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Yong‐Su Zhen (27 shared papers)Liang Li (12 shared papers)Jianhua Gong (7 shared papers)Shenghua Zhang (7 shared papers)Qingfang Miao (8 shared papers)Liang Li (6 shared papers)Mingliang Liu (5 shared papers)Yi Li (5 shared papers)
In The Last Decade
Xiujun Liu
57 papers receiving 812 citations
Peers
Comparison fields: 5 of 94
- Oncology 243
- Molecular Biology 417
- Microbiology 37
- Immunology 119
- Organic Chemistry 149
Countries citing papers authored by Xiujun Liu
This map shows the geographic impact of Xiujun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujun Liu more than expected).
Fields of papers citing papers by Xiujun Liu
This network shows the impact of papers produced by Xiujun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujun Liu. The network helps show where Xiujun Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiujun Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 65 | |
| 2 | 2017 | 52 | |
| 3 | 2016 | 45 | |
| 4 | 2014 | 33 | |
| 5 | 2018 | 31 | |
| 6 | 2010 | 29 | |
| 7 | 2016 | 29 | |
| 8 | 2017 | 28 | |
| 9 | 2021 | 26 | |
| 10 | 2018 | 25 | |
| 11 | 2012 | 25 | |
| 12 | 2018 | 22 | |
| 13 | 2017 | 22 | |
| 14 | 2019 | 21 | |
| 15 | 2015 | 20 | |
| 16 | 2015 | 19 | |
| 17 | 2022 | 19 | |
| 18 | 2017 | 18 | |
| 19 | 2012 | 17 | |
| 20 | 2020 | 16 |
About Xiujun Liu
Xiujun Liu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 60 papers that have together received 818 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Cancer therapeutics and mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (243 citations), Molecular Biology (417 citations), Microbiology (37 citations), Immunology (119 citations) and Organic Chemistry (149 citations). Xiujun Liu has collaborated with scholars based in China, Austria and Singapore. Frequent co-authors include Yong‐Su Zhen, Liang Li, Jianhua Gong, Shenghua Zhang, Qingfang Miao, Liang Li, Mingliang Liu, Yi Li, Jian Xu and Ruijuan Gao. Their work appears in journals such as Biochemical Pharmacology, Cancer Letters, Cancer Biology & Therapy, Cancer Chemotherapy and Pharmacology and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.